首页> 外文期刊>Breast cancer research and treatment. >Isogenic human mammary epithelial cell lines: novel tools for target identification and validation. Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition.
【24h】

Isogenic human mammary epithelial cell lines: novel tools for target identification and validation. Comprehensive characterization of an isogenic human mammary epithelial cell model provides evidence for epithelial-mesenchymal transition.

机译:等基因人类乳腺上皮细胞系:用于目标识别和验证的新型工具。等基因人乳腺上皮细胞模型的全面表征为上皮-间质转化提供了证据。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumorigenesis is a multi-step process involving several consecutive genetic alterations resulting in loss of genomic stability and deregulated signal transduction pathways. To study these deregulated processes in vitro, typically established cancer cell lines derived from primary tumors, ascites, or from metastases are used. However, these cancer cell lines reflect only late stages of the tumorigenic process. To better understand the consequences of the sequential genetic alterations in an in vitro model system, we applied consecutive immortalization and transformation of primary human mammary epithelial cells (HMECs) combining shRNA-mediated knockdown of tumor suppressor genes and overexpression of oncogenes. Thereby, we developed a panel of isogenic HMEC-derived cell lines reflecting the multi-step process of tumorigenesis. The immortalized cell lines have a normal epithelial morphology and proliferate indefinitely and anchorage-dependently. In contrast, the transformed cells exhibit mesenchymal-like morphological changes and strong colony-forming activity in soft agar. SNP array analysis showed that none of the cell lines displayed gross chromosomal aberrations in 80?% of the chromosomes. However, massive changes were observed in some chromosomes of the transformed cells indicating that the transformed phenotype is characterized by chromosomal alterations. The isogenic immortalized and transformed cells described here provide a powerful tool for the in vitro validation of target genes for cancer therapy.
机译:肿瘤发生是一个多步骤的过程,涉及几个连续的遗传改变,从而导致基因组稳定性的丧失和信号转导途径的失调。为了在体外研究这些失控的过程,通常使用源自原发性肿瘤,腹水或转移的已建立的癌细胞系。但是,这些癌细胞系仅反映致瘤过程的后期。为了更好地了解体外模型系统中顺序遗传学改变的后果,我们应用了永生化和原代人乳腺上皮细胞(HMEC)的永生化和转化,结合了shRNA介导的肿瘤抑制基因的敲低和癌基因的过表达。因此,我们开发了一组等基因的HMEC衍生细胞系,反映了肿瘤发生的多步过程。永生细胞系具有正常的上皮形态,并无限期地和锚定地增殖。相反,转化的细胞在软琼脂中表现出间充质样的形态变化和强大的集落形成活性。 SNP阵列分析表明,在80%的染色体中没有一个细胞系显示出总的染色体畸变。然而,在转化细胞的某些染色体中观察到大量变化,表明转化表型的特征在于染色体改变。本文所述的等基因永生化和转化细胞为癌症治疗靶基因的体外验证提供了强大的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号